Underuse of procedures for diagnosing XXXX and of therapies for @entity170 in older nursing home residents.

@entity1 @entity170 @entity79 @entity2331 @entity4959 @entity460 @entity560
OBJECTIVE: To investigate the prevalence of @entity170 , the prevalence of utilization of @entity79 ( @entity79 ) measurements for diagnosis of @entity170 , and prevalence of use of @entity460 and @entity560 supplements and other antiresorptive therapies for treatment of @entity170 in postmenopausal @entity1 in an academic nursing home. METHODS: The charts of all @entity1 aged 56 years and older residing in an academic nursing home were analyzed by one of the authors for the prevalence of @entity170 , the prevalence of use of @entity79 measurements to diagnose @entity170 , and the prevalence of use of @entity460 and @entity560 supplements and other antiresorptive therapies for treatment of @entity170 . RESULTS: Of 136 postmenopausal @entity1 , mean age 79 +/- 10 years, 66 (49%) had measurements of @entity79 . Of these 66 @entity1 , 31 (47%) had @entity170 , 21 (32%) had @entity2331 , and 14 (21%) had normal @entity79 . Elemental @entity4959 1500 mg daily was prescribed to 17 of 31 @entity1 (55%) with @entity170 , to 12 of 21 @entity1 (57%) with @entity2331 , to 2 of 14 @entity1 (14%) with normal @entity79 , and to 27 of 70 @entity1 (39%) with no @entity79 obtained. Any dose of @entity460 was prescribed to 78 of 136 elderly @entity1 (58%). @entity560 supplements were prescribed to 13 of 31 @entity1 (42%) with @entity170 , to 9 of 21 @entity1 (43%) with @entity2331 , to 2 of 14 @entity1 (14%) with normal @entity79 , and to 20 of 70 @entity1 (29%) with no @entity79 obtained. @entity560 supplements were prescribed to 44 of 136 elderly @entity1 (32%). Biphosphonates were prescribed to 19 of 31 @entity1 (61%) with @entity170 . Of 20 @entity1 on medications that increased the risk of @entity170 , 6 (30%) had @entity79 measured. Nine of these 20 @entity1 (45%) were on @entity460 supplements. CONCLUSIONS: Older postmenopausal @entity1 in an academic nursing home have a high prevalence of @entity170 and @entity2331 , a low prevalence of measurement of @entity79 , and underuse of @entity460 , @entity560 supplements, and other antiresorptive therapies for treatment of @entity170 .
